ADMA Biologics
ADMA
ADMA
56 hedge funds and large institutions have $84.5M invested in ADMA Biologics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 5 closing their positions.
Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
15
Reduced
13
Closed
5
Calls
$297K
Puts
$1.81M
Net Calls
-$1.51M
Net Calls Change
-$1.51M
Top Buyers
Top Sellers
| 1 |
BC
1
Broadfin Capital
New York
|
$5.61M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$5K |
| 3 |
DG
3
Delek Group
Herzliya,
Israel
|
$241K |
| 4 |
4
Morgan Stanley
New York
|
$148K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$24K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MAM
51
Meeder Asset Management
Dublin,
Ohio
| $4K | 986 | +157 | +19% |
|
|
CG
52
Cutler Group
San Francisco,
California
| $3K | 900 | +900 | New |
|
|
SO
53
STRS Ohio
Columbus,
Ohio
| $1K | 400 | – | – |
|
|
PCP
54
Proficio Capital Partners
Newton,
Massachusetts
| $1K | 236 | +236 | New |
|
|
PVI
55
Pura Vida Investments
New York
| – | – | -37,170 | Closed |
|
|
WAM
56
Weiss Asset Management
Boston,
Massachusetts
| – | – | -17,381 | Closed |
|
57
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | – | -10,000 | Closed |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| $0 | 100 | -4,017 | -98% |
|
|
HIIFS
59
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
| – | – | -3,000 | Closed |
|
60
Simplex Trading
Chicago,
Illinois
| – | – | -284 | Closed |
|
61
Bank of Montreal
Toronto,
Ontario, Canada
| $0 | 12 | -267 | -96% |
|
|
CFGS
62
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
63
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|